Background Demand for treatment for amphetamine use is increasing internationally.
Establishing effective pharmacotherapy provides broader treatment options for people who …

Background Amphetamine use is of concern because it causes a variety of devastating
health physical and neurological consequences, including amphetamine‐induced mental …

Background Stimulant drugs are second only to cannabis as the most widely used class of
illicit drug globally, accounting for 68 million past-year consumers. Dependence on …

Issues. Methamphetamine‐or amphetamine‐type stimulants are the second most frequently
used illicit drug worldwide, second only to cannabis. Behavioural treatments are efficacious …

Background Amphetamine and methamphetamine use disorders are associated with severe
health and social consequences. No pharmacological therapy has been approved for the …

Background Amphetamine dependence is a public health problem with medical, psychiatric,
cognitive, legal and socioeconomic consequences. To date, no pharmacological treatment …

Objectives The study systematically reviewed the effectiveness of pharmacological
treatments alone or combined with brief cognitive-behavioural therapy (BCBT) for treating …

Aims Addiction to methamphetamine/amphetamine (MA/A) is a major public health problem.
Currently there are no pharmacotherapies for MA/A use disorder that have been approved …

Background Few studies examined treatments for amphetamine withdrawal, although it is a
common problem among amphetamine users. Its symptoms, in particular intense craving …

Background Amphetamine withdrawal has been less studied although it is a common
problem with a prevalent rate of 87% among amphetamine users. Its symptoms, in particular …